Protein quality control in Alzheimer's disease by the ubiquitin proteasome system

被引:133
作者
de Vrij, FMS [1 ]
Fischer, DF [1 ]
van Leeuwen, FW [1 ]
Hol, EM [1 ]
机构
[1] Netherlands Inst Brain Res, Grad Sch Neurosci, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1016/j.pneurobio.2004.10.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The ubiquitin proteasome system (UPS) is the major protein quality control system in eukaryotic cells. Many neurodegenerative diseases are characterized by aggregates and inclusions of aberrant proteins, implying a sub-optimal functioning or defective UPS. The last few years have seen increasing evidence for the involvement of the UPS in neurodegenerative disorders, including Alzheimer's disease (AD). Notably, decreases in proteasome activity were detected in several cortical areas in AD patients. In addition, proteins that accumulate in the classical hallmarks of AD were linked to UPS function. This review specifically discusses the involvement of the UPS in AD pathogenesis. First, a detailed overview of the UPS is presented, after which AD pathology and its relation to the UPS is discussed. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:249 / 270
页数:22
相关论文
共 239 条
  • [11] NEOCORTICAL NEUROFIBRILLARY TANGLES CORRELATE WITH DEMENTIA SEVERITY IN ALZHEIMERS-DISEASE
    BIERER, LM
    HOF, PR
    PUROHIT, DP
    CARLIN, L
    SCHMEIDLER, J
    DAVIS, KL
    PERL, DP
    [J]. ARCHIVES OF NEUROLOGY, 1995, 52 (01) : 81 - 88
  • [12] Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation
    Bloom, J
    Amador, V
    Bartolini, F
    DeMartino, G
    Pagano, M
    [J]. CELL, 2003, 115 (01) : 71 - 82
  • [13] Familial Alzheimer's disease-linked presenilin 1 variants elevate A beta 1-42/1-40 ratio in vitro and in vivo
    Borchelt, DR
    Thinakaran, G
    Eckman, CB
    Lee, MK
    Davenport, F
    Ratovitsky, T
    Prada, CM
    Kim, G
    Seekins, S
    Yager, D
    Slunt, HH
    Wang, R
    Seeger, M
    Levey, AI
    Gandy, SE
    Copeland, NG
    Jenkins, NA
    Price, DL
    Younkin, SG
    [J]. NEURON, 1996, 17 (05) : 1005 - 1013
  • [14] Braak H, 1998, PROG BRAIN RES, V117, P267
  • [15] Alzheimer's disease:: intraneuronal alterations precede insoluble amyloid-β formation
    Braak, H
    Del Tredici, K
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 (06) : 713 - 718
  • [16] The base of the proteasome regulatory particle exhibits chaperone-like activity
    Braun, BC
    Glickman, M
    Kraft, R
    Dahlmann, B
    Kloetzel, PM
    Finley, D
    Schmidt, M
    [J]. NATURE CELL BIOLOGY, 1999, 1 (04) : 221 - 226
  • [17] Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice
    Brecht, WJ
    Harris, FM
    Chang, SJ
    Tesseur, I
    Yu, GQ
    Xu, Q
    Fish, JD
    Wyss-Coray, T
    Buttini, M
    Mucke, L
    Mahley, RW
    Huang, YD
    [J]. JOURNAL OF NEUROSCIENCE, 2004, 24 (10) : 2527 - 2534
  • [18] Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
    Buée, L
    Bussière, T
    Buée-Scherrer, V
    Delacourte, A
    Hof, PR
    [J]. BRAIN RESEARCH REVIEWS, 2000, 33 (01) : 95 - 130
  • [19] Ubiquitin and AP180 regulate the abundance of GLR-1 glutamate receptors at postsynaptic elements in C-elegans
    Burbea, M
    Dreier, L
    Dittman, JS
    Grunwald, ME
    Kaplan, JM
    [J]. NEURON, 2002, 35 (01) : 107 - 120
  • [20] Butterfield DA, 2002, NEUROBIOL AGING, V23, P655